Matrix News

Read more
Xylyx Bio awarded $2.2M NIH SBIR Fast-Track grant from National Heart, Lung, and Blood Institute

Press Releases September 2, 2021

Xylyx Bio awarded $2.2M NIH SBIR Fast-Track grant from National Heart, Lung, and Blood Institute

Read more
Extracellular matrix: The secret sauce of 3D cell culture

Media Coverage April 6, 2021

Extracellular matrix: The secret sauce of 3D cell culture

Read more
Xylyx Bio launches specialized contract R&D services that increase predictiveness in antifibrotic drug discovery

Press Releases September 29, 2020

Xylyx Bio launches specialized contract R&D services that increase predictiveness in antifibrotic drug discovery

Read more
Patient-derived organoids transform precision medicine

Media Coverage September 15, 2020

Patient-derived organoids transform precision medicine

Read more
Xylyx Bio releases highly physiologic 2D substrates for improved antifibrotic drug discovery

Press Releases August 26, 2020

Xylyx Bio releases highly physiologic 2D substrates for improved antifibrotic drug discovery

Read more
Xylyx Bio releases advanced disease model system to improve cancer drug discovery

Press Releases May 27, 2020

Xylyx Bio releases advanced disease model system to improve cancer drug discovery

Read more
Evolving tools for accelerating 3D cell culture workflows

Media Coverage February 6, 2020

Evolving tools for accelerating 3D cell culture workflows

Read more
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

Press Releases October 2, 2019

Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

Read more
Cell culture with all the comforts of home

Media Coverage June 1, 2019

Cell culture with all the comforts of home